{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T00:24:35Z","timestamp":1753921475039},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1995,3,1]],"date-time":"1995-03-01T00:00:00Z","timestamp":794016000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Soz Pr\ufffdventivmed"],"published-print":{"date-parts":[[1995,3]]},"DOI":"10.1007\/bf01360324","type":"journal-article","created":{"date-parts":[[2005,3,27]],"date-time":"2005-03-27T17:59:39Z","timestamp":1111946379000},"page":"102-109","source":"Crossref","is-referenced-by-count":2,"title":["Mumpsimpfstoffe: Virologische Grundlagen"],"prefix":"10.1007","volume":"40","author":[{"given":"Angelika","family":"Str\ufffdhle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Germann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1084\/jem.59.1.1","volume":"59","author":"CD Johnson","year":"1934","unstructured":"Johnson CD, Goodpasture EW. An investigation on the etiology of mumps. J Exp Med 1934;59:1?19.","journal-title":"J Exp Med"},{"key":"CR2","first-page":"46","volume":"21","author":"CD Johnson","year":"1935","unstructured":"Johnson CD, Goodpasture E. The etiology of mumps. Am J Hyg 1935;21:46?57.","journal-title":"Am J Hyg"},{"key":"CR3","first-page":"769","volume":"13","author":"EB Buynak","year":"1966","unstructured":"Buynak EB, Hilleman MR. Live attenuated mumps virus vaccine. 1. Vaccine development. Proc Soc Exp Biol Med 1966;13:769?775.","journal-title":"Proc Soc Exp Biol Med"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/oxfordjournals.aje.a120882","volume":"88","author":"K Penttinen","year":"1968","unstructured":"Penttinen K, Cantell K, Somer P, Poikolainen A. Mumps vaccination in the Finnish defense forces. Am J Epidemiol 1968;88:234?244.","journal-title":"Am J Epidemiol"},{"key":"CR5","first-page":"295","volume":"54","author":"K Habel","year":"1951","unstructured":"Habel K. Vaccination of human beings against mumps: Vaccine administered at the start of an epidemic. I. Incidence and severity of mumps in vaccinated and control groups. Am J Hyg 1951;54:295?311.","journal-title":"Am J Hyg"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1099\/0022-1317-63-2-499","volume":"63","author":"OG Andzhaparidze","year":"1982","unstructured":"Andzhaparidze OG, Boriskin YS, Bogomolova NN, Drynov ID. Mumps-virus persistently infected cell cultures release defective interfering virus particles. J Gen Virol 1982;63:499?503.","journal-title":"J Gen Virol"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/0264-410X(88)90097-7","volume":"6","author":"YS Boriskin","year":"1988","unstructured":"Boriskin YS, Kaptsova TI, Lotte VD, Skvortsova OI, \u00d6rvell C. Laboratory markers for overattenuation of mumps vaccine virus. Vacine 1988;6:483?488.","journal-title":"Vacine"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"10424","DOI":"10.1073\/pnas.90.22.10424","volume":"90","author":"ST Nichol","year":"1993","unstructured":"Nichol ST, Rowe JE, Fitch WM. Punctuated equilibrium and positive Darwinian evolution in vesicular stomatitis virus. Proc Natl Acad Sci USA 1993;90:10424?10428.","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0168-1702(89)90054-3","volume":"12","author":"GD Elliot","year":"1989","unstructured":"Elliot GD, Afzal MA, Martin SJ, Rima BK. Nucleotide sequence of a matrix fusion and putative SH protein genes of mumps virus and their deduced amino acid sequences. Virus Res 1989;12:61?75.","journal-title":"Virus Res"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/0042-6822(89)90144-X","volume":"172","author":"A Yamada","year":"1989","unstructured":"Yamada A, Takeuchi K, Tanabayashi K, Hishiyama M, Sugiura A. Sequence variation of the P gene among mumps virus strains. Virology 1989;172:374?376.","journal-title":"Virology"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/BF01309447","volume":"128","author":"RP Yeo","year":"1993","unstructured":"Yeo RP, Afzal MA, Forsey T, Rima BK. Identification of a New Mumps Virus Lineage by Nucleotide Sequence Analysis of the SH Gene of 10 Different Strains. Arch Virol 1993;128:371?377.","journal-title":"Arch Virol"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/BF01321072","volume":"136","author":"U K\u00fcnkel","year":"1994","unstructured":"K\u00fcnkel U, Schreier E, Siegl G, Schultze D. Molecular characterization of mumps virus strains circulating during an epidemic in Eastern Switzerland 1992\/93. Arch Virol 1994;136:433?438.","journal-title":"Arch Virol"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1128\/JVI.17.2.363-373.1976","volume":"17","author":"SC Jensik","year":"1976","unstructured":"Jensik SC, Silver S. Polypeptides of mumps virus. J Virol 1976;17:363?373.","journal-title":"J Virol"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1084\/jem.81.1.93","volume":"81","author":"JF Enders","year":"1945","unstructured":"Enders JF, Kane LW, Cohen S, Levens JH. Immunity in mumps; experiments with monkeys (Macacus mulatta). Development of complement-fixing antibody following infection and experiments on immunization by means of inactivated virus and convalescent human serum. J Exp Med 1945;81:93?117.","journal-title":"J Exp Med"},{"key":"CR15","unstructured":"Lambert B. The frequency of mumps and mumps orchitis and the consequences for sexuality and fertility. Acta Genet 1951;2 (Suppl 1)."},{"key":"CR16","doi-asserted-by":"crossref","unstructured":"Johansson CJ. Clinical studies of sterile couples with special reference to the diagnostic, etiology and prognosis on fertility. Acta Obstet Gynec Scand 1957;36 (Suppl 5).","DOI":"10.3109\/00016345709155392"},{"key":"CR17","first-page":"265","volume":"43","author":"K Penttinen","year":"1979","unstructured":"Penttinen K, Helle E-P, Norrby E. Differences in antibody response induced by formaldehyde inactivated and live mumps vaccines. Develop Biol Standard 1979;43:265?268.","journal-title":"Develop Biol Standard"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/0140-6736(92)92874-F","volume":"340","author":"MA Afzal","year":"1992","unstructured":"Afzal MA, Pickford AR, Forsey T, Minor PD. Heterogeneous mumps vaccine. Lancet 1992;340:980?981.","journal-title":"Lancet"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1001\/archpedi.1969.02100040437004","volume":"118","author":"PA Brunell","year":"1969","unstructured":"Brunell PA, Brickman A, Steinberg S. Evaluation of a live attenuated mumps vaccine (Jeryl Lynn) with observations on the optimal time for testing serologic response. Am J Dis Child 1969;118:435?440.","journal-title":"Am J Dis Child"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3181\/00379727-165-40967","volume":"165","author":"RE Weibel","year":"1980","unstructured":"Weibel RE, Buynak EB, McLean AA, Roehm RR, Hilleman MR. Persistence of antibody in human subjects for 7 to 10 years following administration of combined live attenuated measles, mumps, and rubella virus vaccines (40967). Proc Soc Exp Biol Med 1980;165:260?263.","journal-title":"Proc Soc Exp Biol Med"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/jmv.1890180109","volume":"18","author":"T Popow-Kraupp","year":"1986","unstructured":"Popow-Kraupp T, Kundi M, Ambrosch F, Vanura H, Kunz C. A controlled trial for evaluating two live attenuated mumps-measles vaccines (Urabe AM9-Schwarz and Jeryl Lynn-Moraten) in young children. J Med Virol 1986;18:69?79.","journal-title":"J Med Virol"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0092-1157(83)80021-3","volume":"11","author":"B Christenson","year":"1983","unstructured":"Christenson B, Heller L, Boettiger M. The immunizing effect and reactogenicity of two live attenuated mumps virus vaccines in Swedish schoolchildren. J Biol Standard 1983;11:323?331.","journal-title":"J Biol Standard"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1093\/oxfordjournals.aje.a114037","volume":"121","author":"R Kim-Farley","year":"1985","unstructured":"Kim-Farley R, Bart S, Stetler H, et al. Clinical mumps vaccine efficacy. Am J Epidemiol 1985;121:593?597.","journal-title":"Am J Epidemiol"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0022-3476(05)80726-7","volume":"119","author":"BS Hersh","year":"1991","unstructured":"Hersh BS, Fine PEM, Kent WK, et al. Mumps outbreak in a highly vaccinated population. J Pediatr 1991;119:187?193.","journal-title":"J Pediatr"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0022-3476(68)80334-8","volume":"72","author":"WC Sugg","year":"1968","unstructured":"Sugg WC, Finger JA, Levine RH, Pagano JS. Field evaluation of live mumps vaccine. J Pediatr 1968;72:461?466.","journal-title":"J Pediatr"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1099\/00222615-41-1-1","volume":"41","author":"T Forsey","year":"1994","unstructured":"Forsey T. Mumps vaccines-current status. J Med Microbiol 1994;41:1?2.","journal-title":"J Med Microbiol"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0140-6736(89)90822-2","volume":"2","author":"W Ehrengut","year":"1989","unstructured":"Ehrengut W. Mumps vaccine and meningitis. Lancet 1989;2:751.","journal-title":"Lancet"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0140-6736(86)91044-5","volume":"1","author":"H Peltola","year":"1986","unstructured":"Peltola H, Heinonen OP. Frequency of true adverse reactions to measles-mumps-rubella vaccine. A double-blind placebo-controlled trial in twins. Lancet 1986;1:939?942.","journal-title":"Lancet"},{"key":"CR29","doi-asserted-by":"crossref","unstructured":"Nalin DR. Mumps vaccine complications: which strain? Lancet 1989; 1369?1390.","DOI":"10.1016\/S0140-6736(89)92004-7"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1099\/0022-1317-71-4-987","volume":"71","author":"T Forsey","year":"1990","unstructured":"Forsey T, Mawn JA, Yates PJ, Bentley ML, Minor PD. Differentiation of vaccine and wild mumps viruses using the polymerase chain reaction and dideoxynucleotide sequencing. J Gen Virol 1990;71:987?990.","journal-title":"J Gen Virol"},{"key":"CR31","first-page":"499","volume":"142","author":"SL Cochi","year":"1988","unstructured":"Cochi SL, Preblud SR, Orenstein WA. Perspectives of relative resurgence of mumps in the United States. Am J Dis Child 1988;142:499?507.","journal-title":"Am J Dis Child"},{"key":"CR32","first-page":"161","volume":"16","author":"K Yamanishi","year":"1973","unstructured":"Yamanishi K, Takahashi M, Ueda S et al. Studies of live mumps virus vaccine. V. Development of a new mumps vaccine ?AM9? by plaque cloning. Biken Journal 1973;16: 161?166.","journal-title":"Biken Journal"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/0140-6736(92)92322-7","volume":"340","author":"A Colville","year":"1992","unstructured":"Colville A, Pugh S. Mumps meningitis and measles, mumps, and rubella vaccine. Lancet 1992;340:786?780.","journal-title":"Lancet"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/0140-6736(92)92873-E","volume":"340","author":"T Forsey","year":"1992","unstructured":"Forsey T, Bentley ML, Minor PD. Mumps vaccines and meningitis. Lancet 1992;340:980.","journal-title":"Lancet"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/BF00158792","volume":"9","author":"G Giammanco","year":"1993","unstructured":"Giammanco G, Livolti S, Salemi I, Bilancia GG, Mauro L. Immune response to simultaneous administration of a combined measles, mumps and rubella vaccine with booster doses of diphtheria-tetanus and poliovirus vaccine. Eur J Epidemiol 1993;9:199?202.","journal-title":"Eur J Epidemiol"},{"key":"CR36","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/BF00146269","volume":"9","author":"S Volti Li","year":"1993","unstructured":"Li Volti S, Giammanco-Bilancia G, Grassi M, Garozzo R, Gl\u00fcck R, Giammanco G. Duration of the immune response to MMR vaccine in children of two age-different groups. Eur J Epidemiol 1993;9:311?314.","journal-title":"Eur J Epidemiol"},{"key":"CR37","first-page":"29","volume":"65","author":"R Gl\u00fcck","year":"1986","unstructured":"Gl\u00fcck R, Hoskins JM, Wegmann A, Just M, Germanier R. Rubini, a new live attenuated mumps vaccine virus strain for human diploid cells. Develop Biol Standard 1986;65:29?35.","journal-title":"Develop Biol Standard"},{"key":"CR38","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0923-2516(06)80116-0","volume":"143","author":"YS Boriskin","year":"1992","unstructured":"Boriskin YS, Yamada A, Kaptsova TI, et al. Genetic evidence for variant selection in the course of dilute passaging of mumps vaccine virus. Res Virol 1992;143:279?283.","journal-title":"Res Virol"},{"key":"CR39","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1099\/0022-1317-75-5-1169","volume":"75","author":"MA Afzal","year":"1994","unstructured":"Afzal MA, Pickford AR, Yates PJ, Forsey T, Minor PD. Matrix protein gene sequence of vaccine and vaccine-associated strains of mumps virus. J Gen Virol 1994;75:1169?1172.","journal-title":"J Gen Virol"},{"key":"CR40","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1056\/NEJM196702022760502","volume":"276","author":"M Hilleman","year":"1967","unstructured":"Hilleman M, Weibel DS, Buynak EB, Stokes JJ, Whitman JEJ. Live attenuated mumps-virus vaccine. 4. Protective efficacy as measured in a field evaluation. N Engl J Med 1967;276:252?259.","journal-title":"N Engl J Med"},{"key":"CR41","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1128\/JVI.53.3.727-734.1985","volume":"53","author":"JS Wolinsky","year":"1985","unstructured":"Wolinsky JS, Waxham MN, Server AC. Protective effects of glycoprotein-specific monoclonal antibodies on the course of experimental mumps virus meningoencephalitis. J Virol 1985;53:727?734.","journal-title":"J Virol"},{"key":"CR42","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1084\/jem.151.2.275","volume":"151","author":"DC Merz","year":"1980","unstructured":"Merz DC, Scheid A, Choppin PW. Importance of antibodies to the fusion glycoprotein of paramyxoviruses in the prevention in the spread of infection. J Exp Med 1980;151:275?288.","journal-title":"J Exp Med"},{"key":"CR43","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/0042-6822(81)90474-8","volume":"109","author":"DC Merz","year":"1981","unstructured":"Merz DC, Scheid A, Choppin PW. Immunological studies of the functions of paramyxovirus glycoproteins. Virology 1981;109: 94?105.","journal-title":"Virology"},{"key":"CR44","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/0042-6822(81)90267-1","volume":"114","author":"DC Merz","year":"1981","unstructured":"Merz DC, Wolinsky JS. Biochemical features of mumps virus neuraminidases and their relationship with pathogenicity. Virology 1981;114:218?227.","journal-title":"Virology"},{"key":"CR45","unstructured":"Anonymus. Meningitis associated with measles-mumps-rubella vaccines. Weekly Epidemiological Record 1992;67:301?302."},{"key":"CR46","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.4049\/jimmunol.102.4.1093","volume":"102","author":"G Shramek","year":"1969","unstructured":"Shramek G, Deinhardt F. Development of an attenuated mumps virus vaccine. II. Immune response of animals to vaccination with inactivated and live attenuated mumps viruses. J Immunol 1969;102:1093?1098.","journal-title":"J Immunol"},{"key":"CR47","unstructured":"Str\u00f6hle A, Germann D. Schnelltest zum Nachweis neutralisierender Antik\u00f6rper gegen Mumpsviren (MuV) [Abstract]. Schweizerische Gesellschaft f\u00fcr Mikrobiologie 1994."},{"key":"CR48","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1620\/tjem.111.229","volume":"111","author":"Y Chiba","year":"1973","unstructured":"Chiba Y, Horino K, Umetsu M, Wataya Y, Chiba S, Nakao T. Virus excretion and antibody response in saliva in natural mumps. Tohoku J Exp Med 1973;111:229?238.","journal-title":"Tohoku J Exp Med"},{"key":"CR49","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4049\/jimmunol.116.1.12","volume":"116","author":"Y Chiba","year":"1976","unstructured":"Chiba Y, Dzierba JL;Morag A, Ogra PL. Cell-mediated immunresponse to mumps virus infection in man. J Immunol 1976;116:12?15.","journal-title":"J Immunol"},{"key":"CR50","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/0140-6736(91)92601-W","volume":"338","author":"DJ Nokes","year":"1991","unstructured":"Nokes DJ, Anderson RM. Vaccine safety versus vaccine efficacy in mass immunisation programmes. Lancet 1991;338:1309?1312.","journal-title":"Lancet"},{"key":"CR51","first-page":"504","volume":"32","author":"Bundesamt f\u00fcr Gesundheitswesen","year":"1992","unstructured":"Bundesamt f\u00fcr Gesundheitswesen. Kleinkinderimpfungen. Eine repr\u00e4sentative Erhebung zur Durchimpfung in der Schweiz 1991. Bull BAG 1992;32:504?507.","journal-title":"Bull BAG"},{"key":"CR52","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1056\/NEJM199411243312101","volume":"331","author":"H Peltola","year":"1994","unstructured":"Peltola H, Heinonen OP, Valle M, et al. The elimination of indigenous measles, mumps, and rubella from finland by a 12-year, two dose vaccination program. N Engl J Med 1994;331:1397?1402.","journal-title":"N Engl J Med"},{"key":"CR53","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1128\/CMR.7.3.277","volume":"7","author":"AG Johnson","year":"1994","unstructured":"Johnson AG. Molecular adjuvants and immunomodulators: new approaches to immunization. Clin Microbiol Rev 1994;7:277?289.","journal-title":"Clin Microbiol Rev"},{"key":"CR54","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1126\/science.8073282","volume":"265","author":"J Sprent","year":"1994","unstructured":"Sprent J, Tough DF. Lymphocyte live-span and memory. Science 1994;265:1395?1400.","journal-title":"Science"},{"key":"CR55","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1126\/science.7521064","volume":"265","author":"NR Rabinovich","year":"1994","unstructured":"Rabinovich NR, McInnes P, Klein DL, Hall BF. Vaccine technologies: view to the future. Science 1994;265:1401?1404.","journal-title":"Science"}],"container-title":["Sozial- und Pr\ufffdventivmedizin SPM"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01360324.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01360324\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01360324","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T11:07:45Z","timestamp":1706094465000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01360324"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,3]]},"references-count":55,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1995,3]]}},"alternative-id":["BF01360324"],"URL":"https:\/\/doi.org\/10.1007\/bf01360324","relation":{},"ISSN":["0303-8408","1420-911X"],"issn-type":[{"value":"0303-8408","type":"print"},{"value":"1420-911X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,3]]}}}